References
- Peschken CA, Wang Y, Abrahamowicz M, et al. Persistent disease activity remains a burden for patients with systemic lupus erythematosus. J Rheumatol. 2019 Feb;46(2):166–175.
- Dall’Era M, Bruce IN, Gordon C, et al. Current challenges in the development of new treatments for lupus. Ann Rheum Dis. 2019 Jun;78(6):729–735.
- Peschken CA, Katz SJ, Silverman E, et al. The 1000 Canadian faces of lupus: Determinants of disease outcome in a large multiethnic cohort. J Rheumatol. 2009 Jun; 36(6):1200–1208.